Please Note:
This profile was automatically generated using 1 reference found on the Internet. This information has not been verified. Learn more...
This profile was automatically generated using 1 reference found on the Internet. This information has not been verified. Learn more...
Web References
-
1. Other press releases
www.igeneon.com/html/pressroom - [Cached]Published on: 7/5/2004 Last Visited: 11/17/2005
Dr. Kurt Eisinger, previously a senior consultant at Czipin&Proudfoot and a project manager at Octapharma, Vienna, began work at igeneon in July 2002. He will lead the IGN301 anti-Lewis Y cancer vaccine project team.
